Search results - ORA - Oxford University Research Archive

« Previous | 1 - 10 of 20 | Next »

1

Journal article

Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol

McGovern, A, Tippu, Z, Hinton, W, et al.
2016-02-29

2

Journal article

Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: a primary care cohort study

Whyte, MB, Joy, M, Hinton, W, et al.
2022-04-18

3

Thesis

Feasibility and utility of automated processing of speech-based cognitive assessments for early Alzheimer's Disease

Aryal Atreya, A
2023

4

Journal article

A review of safety outcomes from clinical trials of baricitinib in rheumatology, dermatology and COVID-19

Bieber, T, Feist, E, Irvine, AD, et al.
2022-09-05

5

Journal article

Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM

Fautrel, B, Kirkham, B, Pope, J, et al.
2019-09-05

6

Journal article

Generalized reduced rank latent factor regression for high dimensional tensor fields, and neuroimaging-genetic applications

Tao, C, Nichols, T, Hua, X, et al.
2016-09-22

7

Conference item

Efficacy and safety of switching from adalimumab to baricitinib: long-term data from phase 3 extension study in patients with rheumatoid arthritis

Weinblatt, M, Taylor, P, Keystone, E, et al.
2018-10-15

8

Journal article

Characterization and changes of lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis: an integrated analysis

Tanaka, Y, McInnes, I, Taylor, P, et al.
2018-07-29

9

Journal article

Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity

Coates, L, Orbai, A, Morita, A, et al.
2018-08-13

10

Journal article

Ixekizumab efficacy and safety with and without concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) in biologic DMARD (bDMARD)-naïve patients with active psoriatic arthritis (PsA): results from SPIRIT-P1

Coates, L, Kishimoto, M, Gottlieb, A, et al.
2017-12-22

TO TOP